日本語 
Pharma
Curatis Holding AG has signed an exclusive licensing and development agreement with Japanese pharma company Neupharma for corticorelin, also known as C-PTBE-01. The research examines how to treat peritumoral brain…
Eisai and Henlius Sign Japan Rights Deal for Serplulimab
Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…
Rakuten Medical and LOTTE Biologics Forge Strategic Manufacturing Alliance to Fuel Global Oncology Programs
Rakuten Medical, Inc., a biotech firm in the U.S., has partnered with…
Kura and Kyowa Report Strong KOMZIFTI AML Data
Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…
Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing
Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…
Ubie and Kameda Hospital Start AI Obesity Treatment PoC
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan
Eisai and its global partner Biogen have filed a new drug application…
Kinko’s and Veeva Japan enter into partnership agreement
Veeva Japan Co., Ltd., the Japanese subsidiary of Veeva Systems, a global…
Otsuka Files FDA application for Centanafadine ADHD Drug
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. announce…
English